SELLAS Life Sciences Group, Inc.
SLS
$1.43
$0.042.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.94M | -26.26M | -27.13M | -30.88M | -32.28M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.47M | 2.34M | 2.16M | 2.13M | 2.23M |
| Change in Net Operating Assets | -7.15M | -7.44M | -8.75M | -6.65M | -3.02M |
| Cash from Operations | -30.62M | -31.36M | -33.71M | -35.40M | -33.07M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -- | -- | -- | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 31.95M | 47.57M | 43.76M | 46.82M | 50.17M |
| Repurchase of Common Stock | -64.00K | -64.00K | -64.00K | -64.00K | -31.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 22.03M | -- | -- | -- | -- |
| Cash from Financing | 53.91M | 47.51M | 43.69M | 46.76M | 50.14M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.29M | 16.15M | 9.98M | 11.36M | 17.06M |